Cormorant Asset Management, LP Avidity Biosciences, Inc. Transaction History

Cormorant Asset Management, LP

$992 Million
Q2 2025

A detailed history of Cormorant Asset Management, LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 200,000 shares of RNA stock, worth $9.24 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

200,000

Previous 400,000 50.0%

Holding current value

$9.24 Million

Previous $11.8 Million 51.9%

% of portfolio

0.57%

Previous 1.25%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$24.08 - $36.24 $4.82 Million - $7.25 Million	-200,000 Reduced 50.0%	200,000 $5.68 Million
Q1 2025 May 15, 2025	SELL	$27.05 - $35.11 $17.6 Million - $22.8 Million	-650,000 Reduced 61.9%	400,000 $11.8 Million
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $23.3 Million - $30.1 Million	625,000 Added 147.06%	1,050,000 $48.2 Million
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $9.66 Million - $17.4 Million	425,000 New	425,000 $17.4 Million
Q3 2023 Nov 14, 2023	SELL	$6.3 - $11.35 $5.36 Million - $9.65 Million	-850,000 Reduced 32.54%	1,762,115 $11.2 Million
Q1 2023 May 15, 2023	SELL	$15.35 - $25.65 $2.3 Million - $3.85 Million	-150,000 Reduced 5.43%	2,612,115 $40.1 Million
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $7.55 Million - $17 Million	750,000 Added 37.27%	2,762,115 $61.3 Million
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $3.06 Million - $4.3 Million	-150,000 Reduced 6.94%	2,012,115 $47.8 Million
Q3 2021 Nov 15, 2021	SELL	$18.16 - $25.21 $1.21 Million - $1.68 Million	-66,552 Reduced 2.99%	2,162,115 $53.3 Million
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $4.63 Million - $6.9 Million	-235,878 Reduced 9.57%	2,228,667 $55.1 Million
Q1 2021 May 17, 2021	SELL	$20.28 - $28.15 $40 - $56	-2 Reduced -0.0%	2,464,545 $53.8 Million
Q4 2020 Feb 16, 2021	SELL	$24.73 - $35.12 $1.24 Million - $1.76 Million	-49,999 Reduced 1.99%	2,464,547 $62.9 Million
Q3 2020 Nov 16, 2020	SELL	$23.35 - $35.94 $23 - $35	-1 Reduced -0.0%	2,514,546 $69.5 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $66.9 Million - $79.2 Million	2,514,547 New	2,514,547 $67.8 Million

Others Institutions Holding RNA

# of Institutions

232

Shares Held

119M

Call Options Held

340K

Put Options Held

145K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.41B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Avidity Biosciences, Inc. Transaction History